Carl D Quinion

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

J. Byrd, C. Chen, R. Baiocchi, 2011, Blood.

Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma.

J. Byrd, G. Lozanski, M. Prætorius-Ibba, 2008, Blood.

Combination anti-CD 74 ( milatuzumab ) and anti-CD 20 ( rituximab ) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma

J. Byrd, G. Lozanski, M. Prætorius-Ibba, 2011 .

FTY 720 increases CD 74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death

J. Byrd, C. Chen, M. Prætorius-Ibba, 2011 .

De novo CD5+ diffuse large B‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort

G. Lozanski, A. Evens, K. Blum, 2016, American journal of hematology.